In vivo genome editing restores haemostasis in a mouse model of haemophilia
about
Cas9 as a versatile tool for engineering biologyRNA-guided human genome engineering via Cas9Clinical development of gene therapy: results and lessons from recent successesIn Vivo Delivery Systems for Therapeutic Genome EditingCustomizing the genome as therapy for the β-hemoglobinopathiesGenome-editing Technologies for Gene and Cell TherapyTowards a new era in medicine: therapeutic genome editingFrom Gene Targeting to Genome Editing: Transgenic animals applications and beyondEnabling functional genomics with genome engineeringEngineered Viruses as Genome Editing DevicesDesigned nucleases for targeted genome editingThe gene therapy journey for hemophilia: are we there yet?Hematopoietic stem cell engineering at a crossroadsHuman pluripotent stem cells for modelling human liver diseases and cell therapyProgress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseasesAnimal models of hemophiliaCurrent translational and clinical practices in hematopoietic cell and gene therapyGenome-editing technologies for gene correction of hemophiliaGenome editing: the road of CRISPR/Cas9 from bench to clinicCRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human CellsThe potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challengesGenetically engineered mouse models in oncology research and cancer medicineThe application of genome editing in studying hearing lossGene therapy for hemophiliaLiver-targeted gene therapy: Approaches and challengesTherapeutic genome editing: prospects and challengesGene therapy in an era of emerging treatment options for hemophilia BPleiotropy in complex traits: challenges and strategiesA universal system to select gene-modified hepatocytes in vivoZFN, TALEN, and CRISPR/Cas-based methods for genome engineeringUsher syndrome: Hearing loss, retinal degeneration and associated abnormalities.Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transferTherapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoOligonucleotide-based strategies to combat polyglutamine diseases.CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.ENU Mutagenesis in the Mouse.Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.Gene transfer in the liver using recombinant adeno-associated virusThe scientific quest for lasting youth: prospects for curing aging.CRISPR/Cas9 for genome editing: progress, implications and challenges.
P2860
Q24564294-DE3AFF04-1F99-4949-8670-53CAA2F4296CQ24598394-5EA7A117-14F0-4533-B607-8D791C7BBFDDQ26743393-1195FB4F-6912-492B-B71C-14092FA7AF0AQ26748886-A88EBD6A-C8AD-44D2-84FB-AD65E657FB36Q26751061-8066ABBB-CB95-41DC-8BDB-037E06799B8CQ26769662-C4A531B7-31DE-4E87-ACD4-D27CF9D1F145Q26773287-F4586FF4-0BDE-420B-85D2-BE1F3930142AQ26781859-C4FACDDE-0E3D-4BBE-ACFB-34A640D2457AQ26782747-7EE2A644-5B2E-4F03-BF05-5D2D907E3F10Q26785927-C39E9CF7-57A0-4A51-AB21-E7CB58D561F1Q26787105-DD12E34F-F199-44F4-B595-961C706ECE81Q26823818-698D5417-AC02-4EE9-B223-54EB157AF3FBQ27001570-55F1A5D6-969A-4C65-A1FD-760B86060998Q27005360-37CD1B90-861D-4070-9361-22ABB4392D0DQ27011249-189D8F70-CC4C-44DE-9536-BE5E5CD2F2D7Q27012571-2CB278CD-E4C7-4368-BAC2-719992EE5129Q27024456-283A4532-6338-40B0-A736-66B0470EA71FQ28066273-9008EB7E-24A9-4147-BC79-D9B7CF78B623Q28066970-A03BC801-B9B9-4F8A-9D7A-E4A210B2BE6DQ28076522-284401E2-E69C-4717-9D96-B44DCD91668DQ28077484-1F0B4D61-72E3-4DFA-8F97-7023F14F1477Q28079323-E195C82F-3B4E-4E21-A90E-1FC5C005B3F7Q28081706-98710956-9D3D-470F-9294-7D47B89E9370Q28081911-0C8CFC9D-3A4B-4C25-9B50-6F4FD278875FQ28085748-F1EB3FD9-84F7-49F3-8E47-D4F4B6FAEFF9Q28087380-DC9AD386-4920-4892-AE01-36837F84BE97Q28087557-05356DCE-1A7E-45E2-A2CC-14F82D80D0C4Q28390545-652914B8-8C07-4E9C-A16B-8D327812B816Q28468539-6154A066-8FC5-41A9-A5A7-782B286C3F08Q29615505-3DE7E2B5-90C6-4739-8647-20BC7CC47ECEQ30389509-EDADCF37-D016-4AFD-B011-1F33BD0E7A6DQ30515514-BA7C42BC-AAB9-4AF6-A100-39755D591F76Q33652566-0D5565B7-ADF5-4E44-B1FC-0EF0873EF4F4Q33791247-9B8FC3CB-C63F-4626-811B-E8094FEE309CQ33830117-A11AE12A-4D71-47DE-8E18-D6C3A8B00B9EQ33964080-4664FD5D-D704-4D1D-8005-45323C22914CQ34040385-F72B0FF1-794E-4890-B2F7-5B2F40125AF2Q34164885-67F3D81D-A3ED-4590-8B9D-4220B4352D1EQ34371037-F59CDA10-ADFA-4D3B-B849-35D9ECBEB86DQ34411191-85672EA4-636B-428E-A9AC-5B2878500B8B
P2860
In vivo genome editing restores haemostasis in a mouse model of haemophilia
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@ast
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@en
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@nl
type
label
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@ast
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@en
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@nl
prefLabel
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@ast
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@en
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
In vivo genome editing restores haemostasis in a mouse model of haemophilia
@en
P2093
Anand S Bhagwat
David E Paschon
Edward J Rebar
Fayaz R Khazi
Jonathan D Finn
Lacramiora Ivanciu
Michael C Holmes
Nirav Malani
Samuel L Murphy
P2860
P2888
P304
P3181
P356
10.1038/NATURE10177
P407
P50
P577
2011-06-26T00:00:00Z
P5875
P6179
1041862601